AEG-1 3'-untranslated region functions as a ceRNA in inducing epithelial-mesenchymal transition of human non-small cell lung cancer by regulating miR-30a activity

European Journal of Cell Biology

Volumn 94, Issue 1, 2015, Pages 22-31

  Liu, Kunmei ^a,b   Guo, Le ^b   Guo, Yongjian ^a   Zhou, Bo ^a   Li, Tong ^a   Yang, Hua ^b   Yin, Runting ^c   Xi, Tao ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

^c NANTONG UNIVERSITY   (China)

Author keywords

AEG 1; Competitive endogenous RNAs (ceRNAs); Epithelial mesenchymal transition (EMT); Lung cancer; MiR 30a; Snail; Vimentin

Indexed keywords

AEG 1 PROTEIN; MICRORNA; MICRORNA 30A; NERVE CELL ADHESION MOLECULE; PROTEIN; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; 3' UNTRANSLATED REGION; CELL ADHESION MOLECULE; MESSENGER RNA; MIRN30 MICRORNA, HUMAN; MTDH PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; A549 CELL LINE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG METASTASIS; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; PROTEIN RNA BINDING; UPREGULATION; BIOSYNTHESIS; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

GASTROPODA;

3' UNTRANSLATED REGIONS; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; HEK293 CELLS; HUMANS; LUNG NEOPLASMS; MICRORNAS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84939252155     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2014.10.006     Document Type: Article

References (39)

1. Arancio W. A bioinformatics analysis of Lamin-A regulatory network: a perspective on epigenetic involvement in Hutchinson-Gilford progeria syndrome. Rejuvenation Res. 2012, 15:123-127.
2. Arancio W., Giordano C., Pizzolanti G. A ceRNA analysis on LMNA gene focusing on the Hutchinson-Gilford progeria syndrome. J. Clin. Bioinf. 2013, 3:2.
3. Cai Y., Yu X., Hu S., Yu J. A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinf. 2009, 7:147-154.
4. Camara J., Jarai G. Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha. Fibrog. Tissue Repair 2010, 3:2.
5. Cheng C.W., Wang H.W., Chang C.W., Chu H.W., Chen C.Y., Yu J.C., Chao J.I., Liu H.F., Ding S.L., Shen C.Y. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Breast Cancer Res. Treat. 2012, 134:1081-1093.
6. Chunhacha P., Sriuranpong V., Chanvorachote P. Epithelial-mesenchymal transition mediates anoikis resistance and enhances invasion in pleural effusion-derived human lung cancer cells. Oncol. Lett. 2013, 5:1043-1047.
7. Croce C.M., Calin G.A. miRNAs, cancer, and stem cell division. Cell 2005, 122:6-7.
8. Fang L., Du W.W., Yang X., Chen K., Ghanekar A., Levy G., Yang W., Yee A.J., Lu W.Y., Xuan J.W., Gao Z., Xie F., He C., Deng Z., Yang B.B. Versican 3'-untranslated region (3'-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity. FASEB J. 2013, 27:907-919.
9. Figliuzzi M., Marinari E., De Martino A. MicroRNAs as a selective channel of communication between competing RNAs: a steady-state theory. Biophys. J. 2013, 104:1203-1213.
10. Gerard C., Novak B. microRNA as a potential vector for the propagation of robustness in protein expression and oscillatory dynamics within a ceRNA network. PLoS One 2013, 8:e83372.
11. Guan P., Yin Z., Li X., Wu W., Zhou B. Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J. Exp. Clin. Cancer Res. 2012, 31:54.
12. He X.X., Chang Y., Meng F.Y., Wang M.Y., Xie Q.H., Tang F., Li P.Y., Song Y.H., Lin J.S. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2012, 31:3357-3369.
13. Huang C.Y., Lin C.Y., Tsai C.W., Yin M.C. Inhibition of cell proliferation, invasion and migration by ursolic acid in human lung cancer cell lines. Toxicol. In Vitro 2011, 25:1274-1280.
14. Karreth F.A., Tay Y., Perna D., Ala U., Tan S.M., Rust A.G., DeNicola G., Webster K.A., Weiss D., Perez-Mancera P.A., Krauthammer M., Halaban R., Provero P., Adams D.J., Tuveson D.A., Pandolfi P.P. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 2011, 147:382-395.
15. Kasai H., Allen J.T., Mason R.M., Kamimura T., Zhang Z. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res. 2005, 6:56.
16. Kumar M.S., Armenteros-Monterroso E., East P., Chakravorty P., Matthews N., Winslow M.M., Downward J. HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature 2014, 505:212-217.
17. Kumarswamy R., Mudduluru G., Ceppi P., Muppala S., Kozlowski M., Niklinski J., Papotti M., Allgayer H. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. Int. J. Cancer 2012, 130:2044-2053.
18. Lee D.Y., Shatseva T., Jeyapalan Z., Du W.W., Deng Z., Yang B.B. A 3'-untranslated region (3'UTR) induces organ adhesion by regulating miR-199a* functions. PLoS One 2009, 4:e4527.
19. Li J., Chen Y., Zhao J., Kong F., Zhang Y. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer Lett. 2011, 304:52-59.
20. Li J., Zhang Y., Zhao J., Kong F., Chen Y. Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells. Mol. Cell. Biochem. 2011, 357:31-38.
21. Li X., Kong X., Huo Q., Guo H., Yan S., Yuan C., Moran M.S., Shao C., Yang Q. Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. Cancer Sci. 2011, 102:1151-1157.
22. Liu K., Yan Z., Li Y., Sun Z. Linc2GO: a human LincRNA function annotation resource based on ceRNA hypothesis. Bioinformatics 2013, 29:2221-2222.
23. Nurwidya F., Takahashi F., Murakami A., Takahashi K. Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer. Cancer Res. Treat. 2012, 44:151-156. (Official Journal of Korean Cancer Association).
24. Qian B., Nag S.A., Su Y., Voruganti S., Qin J.J., Zhang R., Cho W.C. miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents. Curr. Cancer Drug Targets 2013, 13:519-541.
25. Rubio-Somoza I., Weigel D., Franco-Zorilla J.M., Garcia J.A., Paz-Ares J. ceRNAs: miRNA target mimic mimics. Cell 2011, 147:1431-1432.
26. Shi J., Wang D.M., Wang C.M., Hu Y., Liu A.H., Zhang Y.L., Sun B., Song J.G. Insulin receptor substrate-1 suppresses transforming growth factor-beta1-mediated epithelial-mesenchymal transition. Cancer Res. 2009, 69:7180-7187.
27. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J. Clin. 2013, 63:11-30.
28. Soini Y. Tight junctions in lung cancer and lung metastasis: a review. Int. J. Clin. Exp. Pathol. 2012, 5:126-136.
29. Su X., Xing J., Wang Z., Chen L., Cui M., Jiang B. microRNAs and ceRNAs: RNA networks in pathogenesis of cancer. Chin. J. Cancer Res.=Chung-kuo yen cheng yen chiu 2013, 25:235-239.
30. Sumazin P., Yang X., Chiu H.S., Chung W.J., Iyer A., Llobet-Navas D., Rajbhandari P., Bansal M., Guarnieri P., Silva J., Califano A. An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 2011, 147:370-381.
31. Stenvang Jan, Andreas Petri, Morten Lindow, Susanna Obad, Sakari Kauppinen Inhibition of microrna function by antimir oligonucleotides. Silence 2012, 3:1.
32. Tan X., Qin W., Zhang L., Hang J., Li B., Zhang C., Wan J., Zhou F., Shao K., Sun Y., Wu J., Zhang X., Qiu B., Li N., Shi S., Feng X., Zhao S., Wang Z., Zhao X., Chen Z., Mitchelson K., Cheng J., Guo Y., He J. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Clin. Cancer Res. 2011, 17:6802-6811.
33. Tay Y., Kats L., Salmena L., Weiss D., Tan S.M., Ala U., Karreth F., Poliseno L., Provero P., Di Cunto F., Lieberman J., Rigoutsos I., Pandolfi P.P. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 2011, 147:344-357.
34. Wei J., Li Z., Chen W., Ma C., Zhan F., Wu W., Peng Y. AEG-1 participates in TGF-beta1-induced EMT through p38 MAPK activation. Cell Biol. Int. 2013, 37:1016-1021.
35. Yang W., Yee A.J. Versican 3'-untranslated region (3'UTR) promotes dermal wound repair and fibroblast migration by regulating miRNA activity. Biochim. Biophys. Acta 2014, 1843:1373-1385.
36. Yoo B.K., Emdad L., Lee S.G., Su Z.Z., Santhekadur P., Chen D., Gredler R., Fisher P.B., Sarkar D. Astrocyte elevated gene-1 (AEG-1): a multifunctional regulator of normal and abnormal physiology. Pharmacol. Ther. 2011, 130:1-8.
37. Yoo B.K., Emdad L., Su Z.Z., Villanueva A., Chiang D.Y., Mukhopadhyay N.D., Mills A.S., Waxman S., Fisher R.A., Llovet J.M., Fisher P.B., Sarkar D. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J. Clin. Invest. 2009, 119:465-477.
38. Zhang B., Liu X.X., He J.R., Zhou C.X., Guo M., He M., Li M.F., Chen G.Q., Zhao Q. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis 2011, 32:2-9.
39. Zhu K., Dai Z., Pan Q., Wang Z., Yang G.H., Yu L., Ding Z.B., Shi G.M., Ke A.W., Yang X.R., Tao Z.H., Zhao Y.M., Qin Y., Zeng H.Y., Tang Z.Y., Fan J., Zhou J. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin. Cancer Res. 2011, 17:7294-7302.